Health ❯ Biotechnology ❯ Drug Development
Safety Concerns Innovation Challenges Cancer Treatment Monoclonal Antibodies
Targeting acetylated tau, the candidate has entered an FDA-cleared first-in-human trial with Sanofi set to lead later development.
